These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20838048)

  • 1. Neuropsychological predictors of rapidly progressing patients with Alzheimer's disease.
    Musicco M; Salamone G; Caltagirone C; Cravello L; Fadda L; Lupo F; Mosti S; Perri R; Palmer K
    Dement Geriatr Cogn Disord; 2010; 30(3):219-28. PubMed ID: 20838048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Working memory in early Alzheimer's disease: a neuropsychological review.
    Huntley JD; Howard RJ
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):121-32. PubMed ID: 19672843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.
    Palmer K; Lupo F; Perri R; Salamone G; Fadda L; Caltagirone C; Musicco M; Cravello L
    J Alzheimers Dis; 2011; 24(1):35-45. PubMed ID: 21157019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological predictors of dependency in patients with Alzheimer disease.
    Sarazin M; Stern Y; Berr C; Riba A; Albert M; Brandt J; Dubois B
    Neurology; 2005 Mar; 64(6):1027-31. PubMed ID: 15781821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive profiles of incipient dementia in the Goteborg MCI study.
    Nordlund A; Rolstad S; Göthlin M; Edman A; Hansen S; Wallin A
    Dement Geriatr Cogn Disord; 2010; 30(5):403-10. PubMed ID: 20975271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of progression from mild cognitive impairment to Alzheimer disease.
    Palmer K; Berger AK; Monastero R; Winblad B; Bäckman L; Fratiglioni L
    Neurology; 2007 May; 68(19):1596-602. PubMed ID: 17485646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-task performance in Alzheimer's disease, mild cognitive impairment, and normal ageing.
    Foley JA; Kaschel R; Logie RH; Della Sala S
    Arch Clin Neuropsychol; 2011 Jun; 26(4):340-8. PubMed ID: 21576091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl).
    Campanozzi MD; Casali E; Neviani F; Martini E; Neri M
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():91-6. PubMed ID: 17317439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in the treatment of Alzheimer's disease.
    J Clin Psychiatry; 2009 Feb; 70(2):281-90. PubMed ID: 19265644
    [No Abstract]   [Full Text] [Related]  

  • 10. Cognitive deterioration rates in patients with Parkinson's disease from northeastern China.
    Luo XG; Feng Y; Liu R; Yu HM; Wang L; Wu Z; Ren Y; He ZY
    Dement Geriatr Cogn Disord; 2010; 30(1):64-70. PubMed ID: 20689285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EEG abnormalities are associated with different cognitive profiles in Alzheimer's disease.
    Smits LL; Liedorp M; Koene T; Roos-Reuling IE; Lemstra AW; Scheltens P; Stam CJ; van der Flier WM
    Dement Geriatr Cogn Disord; 2011; 31(1):1-6. PubMed ID: 21109738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Executive dysfunction in vascular cognitive impairment in the consortium to investigate vascular impairment of cognition study.
    Moorhouse P; Song X; Rockwood K; Black S; Kertesz A; Gauthier S; Feldman H;
    J Neurol Sci; 2010 Jan; 288(1-2):142-6. PubMed ID: 19840883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
    Giovagnoli AR; Erbetta A; Reati F; Bugiani O
    Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer?
    Vellas B; Andrieu S; Cantet C; Dartigues JF; Gauthier S
    J Nutr Health Aging; 2007; 11(4):338-41. PubMed ID: 17653494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
    Wobrock T; Retz-Junginger P; Retz W; Supprian T; Rösler M
    Fortschr Neurol Psychiatr; 2003 Apr; 71(4):199-204. PubMed ID: 12677553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cut the coda: early fluency intervals predict diagnoses.
    Fernaeus SE; Ostberg P; Hellström A; Wahlund LO
    Cortex; 2008 Feb; 44(2):161-9. PubMed ID: 18387545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive deterioration in Alzheimer's disease: is the early course predictive of the later stages?
    Capitani E; Cazzaniga R; Francescani A; Spinnler H
    Neurol Sci; 2004 Oct; 25(4):198-204. PubMed ID: 15549505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease.
    Rockwood K; Fay S; Gorman M
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):191-201. PubMed ID: 19548273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive function predicts survival in Alzheimer disease: a study in Shanghai.
    Zhou B; Zhao Q; Teramukai S; Ding D; Guo Q; Fukushima M; Hong Z
    J Alzheimers Dis; 2010; 22(2):673-82. PubMed ID: 20847419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verbal cued recall as a predictor of conversion to Alzheimer's disease in Mild Cognitive Impairment.
    Dierckx E; Engelborghs S; De Raedt R; Van Buggenhout M; De Deyn PP; Verté D; Ponjaert-Kristoffersen I
    Int J Geriatr Psychiatry; 2009 Oct; 24(10):1094-100. PubMed ID: 19280679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.